Guardian Pharmacy Services Inc has 14 Schedule 13D or 13G filings on record since 2025-07-17. 2 holders' latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 21.3% | 10,569,491 | SCHEDULE 13D/A, 2026-03-24 | 2026-03-20 |
| Fmr LLC | 6.5% | 2,359,357 | SCHEDULE 13G, 2026-05-06 | 2026-03-31 |
| Brown Advisory Inc | 4.54% | 1,644,569 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Franklin Resources, Inc. | 4.3% | 976,207 | SCHEDULE 13G/A, 2025-08-05 | 2025-06-30 |
| The Vanguard Group | 4.25% | 966,806 | SCHEDULE 13G/A, 2025-07-29 | 2025-06-30 |
| BlackRock, Inc. | 4.2% | 1,507,822 | SCHEDULE 13G/A, 2026-01-21 | 2025-12-31 |
| Wellington Management Group LLP | 3.1% | 1,123,132 | SCHEDULE 13G/A, 2026-02-10 | 2025-12-31 |
| J. Goldman & Co LP | 2.9% | 656,860 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Clearbridge Investments, LLC | 2% | 445,524 | SCHEDULE 13G/A, 2025-08-05 | 2025-06-30 |
Purpose of Transaction (Item 4)
Bindley Capital Partners I, LLC
Item 4 of the Schedule 13D is amended and supplemented as follows: On March 20, 2026, the Reporting Persons sold an aggregate amount of 5,880,000 shares of Class A common stock of the Issuer pursuant to an underwriting agreement, dated as of March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters (the "Underwriters") named therein (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, on March 20, 2026, the Underwriters exercised in full their option to purchase an additional 900,000 shares of Class A common stock from the Reporting Persons.Item 4 of the SCHEDULE 13D/A filed 2026-03-24
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 4% | SCHEDULE 13G/A |
| 2025-07-29 | The Vanguard Group | 4.25% | SCHEDULE 13G/A |
| 2025-07-29 | Bindley Capital Partners I, LLC | 22.3% | SCHEDULE 13D/A |
| 2025-08-05 | Franklin Resources, Inc. | 4.3% | SCHEDULE 13G/A |
| 2025-08-05 | Clearbridge Investments, LLC | 2% | SCHEDULE 13G/A |
| 2025-08-12 | Wellington Management Group LLP | 4.9% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2025-11-12 | Wellington Management Group LLP | 5% | SCHEDULE 13G |
| 2025-11-14 | J. Goldman & Co LP | 2.9% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock, Inc. | 4.2% | SCHEDULE 13G/A |
| 2026-02-10 | Wellington Management Group LLP | 3.1% | SCHEDULE 13G/A |
| 2026-02-13 | Brown Advisory Inc | 4.54% | SCHEDULE 13G/A |
| 2026-03-24 | Bindley Capital Partners I, LLC | 21.3% | SCHEDULE 13D/A |
| 2026-05-06 | Fmr LLC | 6.5% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Guardian Pharmacy Services Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.